Add Angry Lady for a better feeling
Who Should Not Take a Hormone Support Supplement
We checked the help pages of the three largest brands in this category. None of them answers this question. Here is our answer about our own product, including the parts that cost us sales.
Do not take a hormone support supplement without asking a clinician first if you are pregnant, trying to conceive or breastfeeding; if you take tamoxifen; if you have a hormone-sensitive condition or a history of breast cancer; or if you have liver disease. Five more follow below, including one about effectiveness rather than safety. In every case the answer is a conversation, not a purchase.
We sell the product this page is about, and a page like this costs sales the day it goes live. That is why nobody else publishes one, and why this one is worth reading.
Key takeaways
- Nine situations, each traceable to a government health source, a systematic review or a published trial. No blog aggregation.
- Every caution below applies to our own formula. We are not describing someone else's risk.
- Every item ends in a question for a clinician, never an instruction from us.
- If a clinician told you to avoid one specific ingredient, a nine-ingredient formula is the wrong format and single bottles are the right one.
- If severe hot flashes and night sweats are your dominant symptom, hormone therapy has the stronger evidence base. That is a disqualification on effectiveness.
Why you could not find this answer anywhere
You went looking. You typed some version of "who should not take this" and got shipping policies, ingredient marketing and a chat widget offering a discount.
That is not you failing to search. We pulled the live help pages of the three largest menopause supplement brands in July 2026 and checked them against five questions a buyer asks before paying: how much of each ingredient is in it, are those the studied doses, can I take this with hormone therapy, how long until I feel something, and who should not take this. None answers any of the five. All three explain loyalty points.
The nine situations where the answer is not this product
1. You are pregnant, trying to conceive, or breastfeeding. Ask your clinician before taking any botanical supplement. The clearest disqualification here, and it needs no nuance.
2. You take tamoxifen. A 2017 randomized trial of DIM in women taking tamoxifen found it significantly reduced tamoxifen metabolites including endoxifen (P<0.001), and the authors called for research on whether that lessens tamoxifen's clinical benefit. Our formula contains DIM at 150 mg. Raise this with your oncologist before taking any DIM-containing product.
3. You have a hormone-sensitive condition, or a history of breast cancer. Chasteberry acts on prolactin signalling, and hormone-active botanicals are a standing question in breast, uterine and ovarian conditions and in endometriosis and fibroids. The NHS states that black cohosh, red clover, isoflavones and vitamin E are not recommended after breast cancer. Our formula contains black cohosh.
4. You have liver disease, or a history of liver injury. The NIH documents at least 83 worldwide reports of liver injury associated with black cohosh, with no causal relationship established and an estimated rate between 1 in 14,000 and 1 in 100,000. It lands on our product at 80 mg.
5. You are on hormone therapy and have not asked about interactions. The NHS names St John's wort as affecting how hormone therapy works and lists black cohosh among the herbals taken alongside it. Being on hormone therapy does not rule a supplement out. It means the question belongs to your prescriber.
6. You already take a vitamin D supplement or a multivitamin. Our formula contains 4,000 IU of vitamin D3, exactly the Tolerable Upper Intake Level for adults, plus zinc picolinate at 15 mg, 1.9 times the 8 mg RDA for adult women. Stacking can put you higher than you intend.
7. You take a prescription medicine of any kind. Botanical and mineral interactions are why pharmacists exist. Bring the label, not the marketing page.
8. Your estrogen is already low. Practitioner sources report that DIM can worsen symptoms when estrogen is already low. Clinical opinion rather than trial evidence, labelled as such, and worth raising.
9. Your dominant symptom is severe hot flashes and night sweats. A disqualification on effectiveness rather than safety. Nothing on a supplement shelf, ours included, matches clinician-guided hormone therapy there. The FDA removed the boxed warning from many hormone therapy products in November 2025, reopening a decision many women closed years ago.
If one of those applies, here is what remains
| Option | Strongest advantage | Weakest point | Best for |
|---|---|---|---|
| Clinician-guided hormone therapy | The deepest evidence base of anything here | Needs a prescriber, and is not for everyone | Significant vasomotor symptoms |
| Prescription nonhormonal options | Prescriber oversight and FDA review | Narrow target | A contraindication to hormones |
| Lifestyle change alone | Free, and interacts with nothing | Slow | Everyone, at any stage |
| A single ingredient | One variable to clear with a clinician instead of nine | One lever against a multi-system change | Anyone under an ingredient-specific restriction |
| Doing nothing | Zero interaction risk | The waiting can run years | Mild symptoms |
If a clinician told you to avoid one specific ingredient, the fourth row is the honest answer and it is not us. A nine-ingredient formula cannot have one ingredient removed. A shelf of single bottles can.
What we can and cannot tell you about our own bottle
Angry Lady publishes 9 clinically studied ingredients and dosages. The reason that matters here is narrow: you cannot bring a proprietary blend to a pharmacist and get a useful answer.
If your clinician asks how much black cohosh you would be taking, the answer is 80 mg. If she asks about the DIM, 150 mg. If she asks how much sits inside an undisclosed blend, none. That is the whole benefit claimed here. Not that our formula is safer. That it can be checked.
Where this is not your best option
We have no finished-product clinical trial. Bonafide Relizen cites placebo-controlled trials on its finished product and Amberen cites its own. We have research on individual ingredients and none on the finished formula. Those studies are company-sponsored and both labels keep their doses hidden, but on this measure they are ahead of us.
One of our nine is unresolved, and one carries a limit that belongs here. Red maca at 1,000 mg sits inside the range where effects have been observed, from 300 mg of a concentrated extract in perimenopausal women up to gram-scale raw powder, but the herb equivalent depends on an extract ratio we have not published, so we will not call it settled. DIM at 150 mg matches a studied dose exactly, 551 women over six months, and that trial was null on its own endpoints. The ingredient carrying the tamoxifen caution carries the weakest outcome evidence.
Our black cohosh label does not publish an extraction solvent or a drug-extract ratio. Those two figures, not the triterpene glycoside percentage, are how the European Medicines Agency defines a black cohosh preparation. Until we publish ours, our 80 mg cannot be mapped onto any preparation carrying efficacy evidence, and we make no symptom claim from it.
If you need to avoid one ingredient, buy singles. A combined formula is the wrong format under an ingredient-specific restriction, and disclosure does not change that.
See every ingredient and dose →
Frequently asked questions
Who should not take a hormone support supplement?
Anyone pregnant, trying to conceive or breastfeeding; anyone on tamoxifen; anyone with a hormone-sensitive condition or a history of breast cancer; anyone with liver disease; anyone on hormone therapy or another prescription who has not asked; anyone already taking a multivitamin or vitamin D; and anyone whose estrogen is already low.
Can I take this if I am on tamoxifen?
Ask your oncologist first. A 2017 randomized trial found DIM significantly reduced tamoxifen metabolites including endoxifen, and our formula contains DIM at 150 mg. This is the most specific and least known item on the list.
Is it safe to take with hormone therapy?
That question belongs to your prescriber, and it can only be answered with the amounts in front of them. It changes who gets to decide, not whether the answer can be yes.
I have had breast cancer. Can I take this?
The NHS does not recommend black cohosh, red clover, isoflavones or vitamin E for women who have had breast cancer. Our formula contains black cohosh. Speak to your specialist first.
Why would a company publish a list like this?
Because what a company withholds tells you what it optimizes for. If a brand will not say who should avoid its product, assume it has not asked.
The absence was never accidental
A category cannot claim to be health-adjacent and refuse to publish its own exclusion criteria. Every brand that has run the numbers on a page like this reached the same conclusion, which is why the section does not exist.
You asked a reasonable question and could not find an answer. That was never a failure of your searching. It was a shelf of companies that decided the answer was too expensive to publish. You are allowed to be told who should not take something before you are told who should.
Angry Lady publishes this article and sells the supplement described in it, and earns money when you buy it. This page is designed to talk some readers out of buying, which is a strange thing for a seller to publish and is the reason it is worth reading. Nothing here is medical advice. Every caution is sourced. Our editorial standards, including how we select sources and how to report an error, are available on request at support@getangrylady.com.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Results referenced are from clinical studies on individual ingredients at their studied dosages and may not reflect individual results.